Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box P3 (FOXP3)-bound regulatory DNA sequences are specific genomic regions, including promoters and enhancers, that are physically occupied by the FOXP3 transcription factor to orchestrate the gene expression program of regulatory T cells (Tregs). These sequences are essential for maintaining immune tolerance and preventing autoimmunity, as FOXP3 binds to them—often in cooperation with partners like NFAT or Runx1—to repress pro-inflammatory genes such as IL2 and activate suppressive markers like CTLA4 and CD25. The binding sites are typically characterized by the 'GTAAACA' motif, and their accessibility is often regulated by epigenetic modifications. Mutations in the FOXP3 DNA-binding domain (FKH domain) disrupt these interactions, leading to severe autoimmune disorders like IPEX syndrome. In the context of cancer, FOXP3-mediated regulation in Tregs contributes to an immunosuppressive tumor microenvironment, making the disruption of FOXP3-DNA binding a significant therapeutic objective. Current drug development strategies include antisense oligonucleotides to reduce FOXP3 levels and specialized peptides designed to inhibit FOXP3's ability to bind to these regulatory DNA sequences or its essential co-regulatory partners.
Modulation of FOXP3-mediated gene transcription through inhibition of DNA binding, disruption of FOXP3-transcription factor complexes, or antisense-mediated knockdown of FOXP3 expression.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box P3-bound regulatory DNA sequences (FOXP3-bound DNA).